Lista de obras -

1792Higher Adherence to an Inpatient Treatment Guideline for Community-acquired Pneumonia is Associated with Reduced Mortality in Botswana

artículo científico publicado en 2014

A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens

artículo científico publicado en 2015

A replication-competent, neuronal spread-defective, live attenuated herpes simplex virus type 1 vaccine

artículo científico publicado en 2008

A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia.

artículo científico publicado en 2005

A trivalent gC2/gD2/gE2 vaccine for herpes simplex virus generates antibody responses that block immune evasion domains on gC2 better than natural infection

scientific article published on 12 December 2018

A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model

artículo científico publicado en 2017

Access to multidisciplinary cancer care: is it linked to the use of breast-conserving surgery with radiation for early-stage breast carcinoma?

artículo científico publicado en 2004

Adopting an ethical approach to global health training: the evolution of the Botswana - University of Pennsylvania partnership

artículo científico publicado en 2013

An HSV-1 gD mutant virus as an entry-impaired live virus vaccine

artículo científico publicado en 2008

An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs.

artículo científico publicado en 2017

An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection

artículo científico publicado en 2020

Anterograde spread of herpes simplex virus type 1 requires glycoprotein E and glycoprotein I but not Us9.

scientific article published on July 2009

Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants

artículo científico publicado en 2019

Bacillus Cereus

scholarly article published in 2017

Better neutralization of herpes simplex virus type 1 (HSV-1) than HSV-2 by antibody from recipients of GlaxoSmithKline HSV-2 glycoprotein D2 subunit vaccine

artículo científico publicado en 2014

Blocking Immune Evasion as a Novel Approach for Prevention and Treatment of Herpes Simplex Virus Infection ⬇️

artículo científico publicado el 1 de diciembre de 2003

Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E

artículo científico publicado en 2008

Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes

artículo científico publicado en 2014

Blood and body fluid exposures among US medical students in Botswana

artículo científico publicado en 2010

Building research capacity through programme development and research implementation in resource-limited settings - the Ipabalele study protocol: observational cohort studies determining the effect of HIV on the natural history of cervical cancer in

artículo científico publicado en 2019

Cervical cancer prevention in HIV-infected women using the "see and treat" approach in Botswana

artículo científico publicado en 2012

Completely assembled virus particles detected by transmission electron microscopy in proximal and mid-axons of neurons infected with herpes simplex virus type 1, herpes simplex virus type 2 and pseudorabies virus

artículo científico publicado en 2010

Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy

artículo científico publicado en 2006

Effect of a rapid response team on patient outcomes in a community-based teaching hospital

artículo científico publicado en 2014

Evaluation of the effect of cellular SMS reminders on consistency of antiretroviral therapy pharmacy pickups in HIV-infected adults in Botswana: a randomized controlled trial

artículo científico publicado en 2017

Exogenous siRNA mediates sequence-independent gene suppression by signaling through toll-like receptor 3.

artículo científico publicado en 2004

Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody.

artículo científico publicado en 2006

Herpes simplex virus type 1 evades the effects of antibody and complement in vivo

artículo científico publicado en 2002

Herpes simplex virus type 1 glycoprotein E mediates retrograde spread from epithelial cells to neurites

artículo científico publicado en 2009

Herpes simplex virus type 1 glycoprotein e is required for axonal localization of capsid, tegument, and membrane glycoproteins

artículo científico publicado en 2005

Herpes simplex virus type 1 infection increases the carbohydrate binding activity and the secretion of cellular galectin-3.

artículo científico publicado en 2009

Herpes simplex virus type 1-encoded glycoprotein C contributes to direct coagulation factor X-virus binding

artículo científico publicado en 2006

Herpes simplex virus type 1-encoded glycoprotein C enhances coagulation factor VIIa activity on the virus

scientific article published on 01 November 2004

Herpes simplex virus type 2 glycoprotein E is required for efficient virus spread from epithelial cells to neurons and for targeting viral proteins from the neuron cell body into axons

artículo científico publicado en 2010

Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection

artículo científico publicado en 2020

Higher set theory and mathematical practice

article published in 1971

Immune evasion by herpes simplex virus type 1, strategies for virus survival

artículo científico publicado en 2003

Immunization strategies to block the herpes simplex virus type 1 immunoglobulin G Fc receptor

artículo científico publicado en 2004

Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine

scientific article published on 15 September 2009

Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compa

artículo científico publicado el 3 de agosto de 2011

Implications for herpes simplex virus vaccine strategies based on antibodies produced to herpes simplex virus type 1 glycoprotein gC immune evasion domains

artículo científico publicado en 2005

Improving immunogenicity and efficacy of vaccines for genital herpes containing herpes simplex virus glycoprotein D.

artículo científico publicado en 2014

Keratin, a dual role in herpes simplex virus pathogenesis

artículo científico publicado en 2006

Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.

artículo científico publicado en 2002

Knowledge of HIV Testing Guidelines Among US Internal Medicine Residents: A Decade After the Centers for Disease Control and Prevention's Routine HIV Testing Recommendations

artículo científico publicado en 2018

Leveraging HIV Programming to Enhance Access to Noncommunicable Disease Care in Southern Botswana

artículo científico publicado en 2015

Live attenuated herpes simplex virus 2 glycoprotein E deletion mutant as a vaccine candidate defective in neuronal spread

artículo científico publicado en 2012

Long Finite Sequences

Medical students in developing countries.

artículo científico publicado en 2011

Molecular association of herpes simplex virus type 1 glycoprotein E with membrane protein Us9.

artículo científico publicado en 2016

Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes

artículo científico publicado en 2019

On Closed Sets of Ordinals

Opinions and attitudes of participants in a randomized controlled trial examining the efficacy of SMS reminders to enhance antiretroviral adherence: a cross-sectional survey

artículo científico publicado en 2014

Out-of-pocket costs of HAART limit HIV treatment responses in Botswana's private sector

artículo científico publicado en 2006

Overestimates of survival after HAART: implications for global scale-up efforts

artículo científico publicado en 2008

Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine

artículo científico publicado en 2020

Protection provided by a herpes simplex virus 2 (HSV-2) glycoprotein C and D subunit antigen vaccine against genital HSV-2 infection in HSV-1-seropositive guinea pigs

artículo científico publicado en 2013

Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy

artículo científico publicado en 2002

Purpura Annularis Telangiectodes of Majocchi Associated With the Initiation and Rechallenge of Apremilast for Psoriasis Vulgaris

artículo científico publicado en 2017

Reducing risk and enhancing education: U.S. medical students on global health electives

artículo científico publicado en 2014

Research Mentoring Plan Involving North-South Collaborations

scientific article published on 01 August 2019

Risk factors for failure to be offered routine HIV testing among adult medical inpatients in Botswana

artículo científico publicado en 2008

Robert Austrian.

artículo científico publicado en 2007

Short interfering RNA-mediated inhibition of herpes simplex virus type 1 gene expression and function during infection of human keratinocytes

artículo científico publicado en 2004

Sinus pause in association with Lyme carditis

artículo científico publicado en 2015

Smart Cup: A Minimally-Instrumented, Smartphone-Based Point-of-Care Molecular Diagnostic Device

artículo científico publicado en 2016

Status of prophylactic and therapeutic genital herpes vaccines

artículo científico

Subtle cardinals and linear orderings

Subtype distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia stages 2 and 3 in Botswana

artículo científico publicado en 2011

Subversion of innate and adaptive immunity: immune evasion from antibody and complement ⬇️

artículo científico publicado el 25 de febrero de 2011

Successful application of prime and pull strategy for a therapeutic HSV vaccine ⬇️

artículo científico publicado en 2019

Sustainable International Partnership Building for Academic Medical Centers: Experiences with the Botswana-UPenn Partnership ⬇️

artículo científico publicado el 1 de marzo de 2010

The herpes simplex virus 1 IgG fc receptor blocks antibody-mediated complement activation and antibody-dependent cellular cytotoxicity in vivo

artículo científico publicado en 2011

Trivalent glycoprotein subunit vaccine prevents neonatal herpes simplex virus mortality and morbidity

scientific article published on 18 March 2020

Tuberculosis among individuals with community-acquired pneumonia presenting to emergency in Gaborone, Botswana

scientific article published on 21 May 2018

Type distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia (CIN) stages 2 and 3 in Botswana.

artículo científico publicado en 2010

Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs.

artículo científico publicado en 2018

Vaccines to prevent genital herpes

scientific article published on 16 March 2020

Yield of screening for TB and HIV among children failing to thrive in Botswana

scientific article published on 27 August 2013

Lista de obras de

1792Higher Adherence to an Inpatient Treatment Guideline for Community-acquired Pneumonia is Associated with Reduced Mortality in Botswana

A Dual-Modality Herpes Simplex Virus 2 Vaccine for Preventing Genital Herpes by Using Glycoprotein C and D Subunit Antigens To Induce Potent Antibody Responses and Adenovirus Vectors Containing Capsid and Tegument Proteins as T Cell Immunogens

A replication-competent, neuronal spread-defective, live attenuated herpes simplex virus type 1 vaccine

A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia.

A trivalent gC2/gD2/gE2 vaccine for herpes simplex virus generates antibody responses that block immune evasion domains on gC2 better than natural infection

A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model

Access to multidisciplinary cancer care: is it linked to the use of breast-conserving surgery with radiation for early-stage breast carcinoma?

Adopting an ethical approach to global health training: the evolution of the Botswana - University of Pennsylvania partnership

An HSV-1 gD mutant virus as an entry-impaired live virus vaccine

An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs.

An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection

Anterograde spread of herpes simplex virus type 1 requires glycoprotein E and glycoprotein I but not Us9.

Antibody responses to crucial functional epitopes as a novel approach to assess immunogenicity of vaccine adjuvants

Bacillus Cereus

Better neutralization of herpes simplex virus type 1 (HSV-1) than HSV-2 by antibody from recipients of GlaxoSmithKline HSV-2 glycoprotein D2 subunit vaccine

Blocking Immune Evasion as a Novel Approach for Prevention and Treatment of Herpes Simplex Virus Infection ⬇️

Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E

Blocking herpes simplex virus 2 glycoprotein E immune evasion as an approach to enhance efficacy of a trivalent subunit antigen vaccine for genital herpes

Blood and body fluid exposures among US medical students in Botswana

Building research capacity through programme development and research implementation in resource-limited settings - the Ipabalele study protocol: observational cohort studies determining the effect of HIV on the natural history of cervical cancer in

Cervical cancer prevention in HIV-infected women using the "see and treat" approach in Botswana

Completely assembled virus particles detected by transmission electron microscopy in proximal and mid-axons of neurons infected with herpes simplex virus type 1, herpes simplex virus type 2 and pseudorabies virus

Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy

Effect of a rapid response team on patient outcomes in a community-based teaching hospital

Evaluation of the effect of cellular SMS reminders on consistency of antiretroviral therapy pharmacy pickups in HIV-infected adults in Botswana: a randomized controlled trial

Exogenous siRNA mediates sequence-independent gene suppression by signaling through toll-like receptor 3.

Herpes simplex virus type 1 and 2 glycoprotein C prevents complement-mediated neutralization induced by natural immunoglobulin M antibody.

Herpes simplex virus type 1 evades the effects of antibody and complement in vivo

Herpes simplex virus type 1 glycoprotein E mediates retrograde spread from epithelial cells to neurites

Herpes simplex virus type 1 glycoprotein e is required for axonal localization of capsid, tegument, and membrane glycoproteins

Herpes simplex virus type 1 infection increases the carbohydrate binding activity and the secretion of cellular galectin-3.

Herpes simplex virus type 1-encoded glycoprotein C contributes to direct coagulation factor X-virus binding

Herpes simplex virus type 1-encoded glycoprotein C enhances coagulation factor VIIa activity on the virus

Herpes simplex virus type 2 glycoprotein E is required for efficient virus spread from epithelial cells to neurons and for targeting viral proteins from the neuron cell body into axons

Herpes simplex virus type 2 trivalent protein vaccine containing glycoproteins C, D and E protects guinea pigs against HSV-1 genital infection

Higher set theory and mathematical practice

Immune evasion by herpes simplex virus type 1, strategies for virus survival

Immunization strategies to block the herpes simplex virus type 1 immunoglobulin G Fc receptor

Immunization with HSV-1 glycoprotein C prevents immune evasion from complement and enhances the efficacy of an HSV-1 glycoprotein D subunit vaccine

Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compa

Implications for herpes simplex virus vaccine strategies based on antibodies produced to herpes simplex virus type 1 glycoprotein gC immune evasion domains

Improving immunogenicity and efficacy of vaccines for genital herpes containing herpes simplex virus glycoprotein D.

Keratin, a dual role in herpes simplex virus pathogenesis

Kinetic analysis of glycoprotein C of herpes simplex virus types 1 and 2 binding to heparin, heparan sulfate, and complement component C3b.

Knowledge of HIV Testing Guidelines Among US Internal Medicine Residents: A Decade After the Centers for Disease Control and Prevention's Routine HIV Testing Recommendations

Leveraging HIV Programming to Enhance Access to Noncommunicable Disease Care in Southern Botswana

Live attenuated herpes simplex virus 2 glycoprotein E deletion mutant as a vaccine candidate defective in neuronal spread

Long Finite Sequences

Medical students in developing countries.

Molecular association of herpes simplex virus type 1 glycoprotein E with membrane protein Us9.

Nucleoside-modified mRNA encoding HSV-2 glycoproteins C, D, and E prevents clinical and subclinical genital herpes

On Closed Sets of Ordinals

Opinions and attitudes of participants in a randomized controlled trial examining the efficacy of SMS reminders to enhance antiretroviral adherence: a cross-sectional survey

Out-of-pocket costs of HAART limit HIV treatment responses in Botswana's private sector

Overestimates of survival after HAART: implications for global scale-up efforts

Protection against herpes simplex virus type 2 infection in a neonatal murine model using a trivalent nucleoside-modified mRNA in lipid nanoparticle vaccine

Protection provided by a herpes simplex virus 2 (HSV-2) glycoprotein C and D subunit antigen vaccine against genital HSV-2 infection in HSV-1-seropositive guinea pigs

Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy

Purpura Annularis Telangiectodes of Majocchi Associated With the Initiation and Rechallenge of Apremilast for Psoriasis Vulgaris

Reducing risk and enhancing education: U.S. medical students on global health electives

Research Mentoring Plan Involving North-South Collaborations

Risk factors for failure to be offered routine HIV testing among adult medical inpatients in Botswana

Robert Austrian.

Short interfering RNA-mediated inhibition of herpes simplex virus type 1 gene expression and function during infection of human keratinocytes

Sinus pause in association with Lyme carditis

Smart Cup: A Minimally-Instrumented, Smartphone-Based Point-of-Care Molecular Diagnostic Device

Status of prophylactic and therapeutic genital herpes vaccines

Subtle cardinals and linear orderings

Subtype distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia stages 2 and 3 in Botswana

Subversion of innate and adaptive immunity: immune evasion from antibody and complement ⬇️

Successful application of prime and pull strategy for a therapeutic HSV vaccine ⬇️

Sustainable International Partnership Building for Academic Medical Centers: Experiences with the Botswana-UPenn Partnership ⬇️

The herpes simplex virus 1 IgG fc receptor blocks antibody-mediated complement activation and antibody-dependent cellular cytotoxicity in vivo

Trivalent glycoprotein subunit vaccine prevents neonatal herpes simplex virus mortality and morbidity

Tuberculosis among individuals with community-acquired pneumonia presenting to emergency in Gaborone, Botswana

Type distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia (CIN) stages 2 and 3 in Botswana.

Vaccine-induced antibodies to herpes simplex virus glycoprotein D epitopes involved in virus entry and cell-to-cell spread correlate with protection against genital disease in guinea pigs.

Vaccines to prevent genital herpes

Yield of screening for TB and HIV among children failing to thrive in Botswana